Trial Profile
Effects of OctaplasLG on Endothelial Integrity in Patients Undergoing Emergency Surgery for Thoracic Aortic Dissections - a Randomized, Controlled, Single-blinded Investigator-initiated Pilot Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Plasma (Primary)
- Indications Aortic aneurysm
- Focus Therapeutic Use
- Acronyms VIPER-OCTA
- 31 May 2018 Results published in the Anesthesia and Analgesia
- 18 Jul 2016 Status changed from active, no longer recruiting to completed.
- 19 Jun 2016 Status changed from recruiting to active, no longer recruiting.